Impact Factor
3.00
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.72
280 total citations
h5-index
21
h5 depth signal
Cited share
65.5%
72 of 110
Total citations
280
Citation footprint
Metric signal
2.23
External metric anchor
Self-citation
31.4%
88 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
255
France
77
Spain
55
Italy
53
Germany
51
Citing Fields of Research
Hematology
420
Clinical Laboratory Science
240
Immunology
175
Lymphomas
168
Oncology
18
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,614
Articles tracked across the journal lifetime
Indexed publication set
110
72 cited publications
Last 12 months
89
7.4 publications/month
Open access share
27.0%
24 OA publications in the last year
Leading citing country
United States
255 citing publications
Leading citing field
Hematology
420 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v51n1, Jan. 2003-
v51n1, Jan. 2003-
Active Coverage
Research Focus & Classification
Indexed Subjects
Hematology
Clinical Laboratory Science
Lymphomas
Issuing & Sponsoring Bodies
Contributor
International Society for Analytical Cytology
Contributor
Clinical Cytometry Society
Broad Categories
Cell Biology
Hematology
Lymphomas
Immunology
MeSH Descriptors
Cytodiagnosis
Flow Cytometry
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1002/cyto.b.70079
Open DOI
Overall concordance may overstate peripheral blood MRD performance in AML remission
03
DOI 10.1002/cyto.b.70075
Open DOI
Evaluation of a multiple myeloma synthetic cell mimic as an assay control for flow cytometry
The reliability of clinical flow cytometry assays hinges on the availability of robust assay controls that accurately reflect representative samples. Widely used conventional assay controls, such as cell lines, often fail to replicate th...
04
DOI 10.1002/cyto.b.70078
Open DOI
Subset‐specific and tissue‐specific expression of NK ‐cell markers and killer immunoglobulin‐like receptors: Implications for NK ‐cell clonality assessment
Accurate immunophenotypic evaluation of natural killer (NK)‐cell neoplasms is challenging because NK‐cells lack somatically rearranged antigen receptors, are comprised of phenotypically distinct subsets, and exhibit tissue‐specific subse...
05
DOI 10.1002/cyto.b.70077
Open DOI
Old data, new tricks: Comprehensive computational analysis of 10 years of multi‐center EuroFlow acute myeloid leukemia diagnostic immunophenotypic data
Acute myeloid leukemia (AML) is characterized by high genotypic and immunophenotypic heterogeneity. We collected an extensive dataset containing 5366 flow cytometry files from 885 AML patients, stained with the EuroFlow acute leukemia or...
06
DOI 10.1002/cyto.b.70076
Open DOI
A practical difference from the normal approach to evaluate natural killer (NK) cells and NK cell neoplasms by flow cytometry
Natural killer (NK) cell neoplasms span indolent to highly aggressive entities, and flow cytometric immunophenotyping is central to their detection and classification. However, distinguishing reactive from neoplastic NK cell expansions c...
07
DOI 10.1002/cyto.b.70074
Open DOI
Characterization of morphological and immunophenotypic heterogeneity in adult T‐cell leukemia/lymphoma and development of a peripheral blood tumor load‐based prognostic index
We evaluated morphologic and immunophenotypic features of adult T‐cell leukemia/lymphoma (ATLL) using morphology and flow cytometry (FCM), compared tumor cell proportions in bone marrow (BM) and peripheral blood (PB), and assessed whethe...
08
09
DOI 10.1002/cyto.b.70068
Open DOI
Circulating tumor plasma cells quantification in newly diagnosed transplant ineligible real world multiple myeloma patients: Comparison of single‐platform flow cytometry versus next generation flow
Circulating tumor plasma cells (CTCs) at diagnosis are independent prognostic markers in newly diagnosed multiple myeloma (NDMM). Flow cytometry (FC) enables sensitive and cost‐effective CTC quantification, but prognostic cut‐offs vary a...
10
DOI 10.1002/cyto.b.70073
Open DOI
Stimulus‐specific interpretation in DHR testing for chronic granulomatous disease
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 60B, no. 1 (July 2004).
Also issued online.
"An official publication of the Clinical Cytometry Society and the International Society for Analytical Cytology."